Literature DB >> 34393610

Bursting Microbubbles: How Nanobubble Contrast Agents Can Enable the Future of Medical Ultrasound Molecular Imaging and Image-Guided Therapy.

Agata A Exner1, Michael C Kolios2.   

Abstract

The field of medical ultrasound has undergone a significant evolution since the development of microbubbles as contrast agents. However, due to their size, microbubbles remain in the vasculature, and therefore have limited clinical applications. Building a better - and smaller - bubble can expand the applications of contrast-enhanced ultrasound by allowing bubbles to extravasate from blood vessels - creating new opportunities. In this review, we summarize recent research on the formulation and use of NBs as imaging agents and as therapeutic vehicles. We discuss the ongoing debates in the field and reluctance to accepting NBs as an acoustically active construct and a potentially impactful clinical tool that can help shape the future of medical ultrasound. We hope that the overview of key experimental and theoretical findings in the NB field presented in this paper provides a fundamental framework that will help clarify NB-ultrasound interactions and inspire engagement in the field.

Entities:  

Keywords:  contrast enhanced ultrasound; drug delivery; microbubbles; molecular imaging; nanobubbles

Year:  2021        PMID: 34393610      PMCID: PMC8356903          DOI: 10.1016/j.cocis.2021.101463

Source DB:  PubMed          Journal:  Curr Opin Colloid Interface Sci        ISSN: 1359-0294            Impact factor:   8.209


  105 in total

1.  High-frequency, nonlinear flow imaging of microbubble contrast agents.

Authors:  David E Goertz; Andrew Needles; Peter N Burns; F Stuart Foster
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2005-03       Impact factor: 2.725

Review 2.  Acoustic behavior of microbubbles and implications for drug delivery.

Authors:  Klazina Kooiman; Hendrik J Vos; Michel Versluis; Nico de Jong
Journal:  Adv Drug Deliv Rev       Date:  2014-03-23       Impact factor: 15.470

3.  High frequency ultrasound nonlinear scattering from porphyrin nanobubbles.

Authors:  Carly Pellow; Josephine Tan; Emmanuel Chérin; Christine E M Demore; Gang Zheng; David E Goertz
Journal:  Ultrasonics       Date:  2020-09-06       Impact factor: 2.890

4.  Development of inherently echogenic liposomes as an ultrasonic contrast agent.

Authors:  H Alkan-Onyuksel; S M Demos; G M Lanza; M J Vonesh; M E Klegerman; B J Kane; J Kuszak; D D McPherson
Journal:  J Pharm Sci       Date:  1996-05       Impact factor: 3.534

5.  Methods of Generating Submicrometer Phase-Shift Perfluorocarbon Droplets for Applications in Medical Ultrasonography.

Authors:  Paul S Sheeran; Naomi Matsuura; Mark A Borden; Ross Williams; Terry O Matsunaga; Peter N Burns; Paul A Dayton
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2016-10-20       Impact factor: 2.725

Review 6.  Nucleic acid delivery with microbubbles and ultrasound.

Authors:  Joshua J Rychak; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2014-01-31       Impact factor: 15.470

7.  Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.

Authors:  Reshani H Perera; Hanping Wu; Pubudu Peiris; Christopher Hernandez; Alan Burke; Helen Zhang; Agata A Exner
Journal:  Nanomedicine       Date:  2016-08-23       Impact factor: 5.307

Review 8.  Therapeutic applications of lipid-coated microbubbles.

Authors:  Evan C Unger; Thomas Porter; William Culp; Rachel Labell; Terry Matsunaga; Reena Zutshi
Journal:  Adv Drug Deliv Rev       Date:  2004-05-07       Impact factor: 15.470

9.  Monodisperse versus Polydisperse Ultrasound Contrast Agents: In Vivo Sensitivity and safety in Rat and Pig.

Authors:  Alexandre Helbert; Emmanuel Gaud; Tim Segers; Catherine Botteron; Peter Frinking; Victor Jeannot
Journal:  Ultrasound Med Biol       Date:  2020-09-30       Impact factor: 2.998

10.  Cryo-EM Visualization of Lipid and Polymer-Stabilized Perfluorocarbon Gas Nanobubbles - A Step Towards Nanobubble Mediated Drug Delivery.

Authors:  Christopher Hernandez; Sahil Gulati; Gabriella Fioravanti; Phoebe L Stewart; Agata A Exner
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

View more
  7 in total

Review 1.  Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound.

Authors:  Scott Schoen; M Sait Kilinc; Hohyun Lee; Yutong Guo; F Levent Degertekin; Graeme F Woodworth; Costas Arvanitis
Journal:  Adv Drug Deliv Rev       Date:  2021-11-18       Impact factor: 15.470

2.  Extrusion: A New Method for Rapid Formulation of High-Yield, Monodisperse Nanobubbles.

Authors:  Claire Counil; Eric Abenojar; Reshani Perera; Agata A Exner
Journal:  Small       Date:  2022-05-19       Impact factor: 15.153

3.  Characterization of the interaction of nanobubble ultrasound contrast agents with human blood components.

Authors:  Michaela B Cooley; Eric C Abenojar; Dana Wegierak; Anirban Sen Gupta; Michael C Kolios; Agata A Exner
Journal:  Bioact Mater       Date:  2022-05-11

Review 4.  Biomedical nanobubbles and opportunities for microfluidics.

Authors:  Ali A Paknahad; Liam Kerr; Daniel A Wong; Michael C Kolios; Scott S H Tsai
Journal:  RSC Adv       Date:  2021-10-05       Impact factor: 4.036

5.  Effects of diagnostic ultrasound with cRGD-microbubbles on simultaneous detection and treatment of atherosclerotic plaque in ApoE-/- mice.

Authors:  Shengcun Guo; Shengye Zhang; Kui Chen; Xi Chen; Fudong Hu
Journal:  Front Cardiovasc Med       Date:  2022-07-22

6.  The unique second wave phenomenon in contrast enhanced ultrasound imaging with nanobubbles.

Authors:  Chuan Chen; Reshani Perera; Michael C Kolios; Hessel Wijkstra; Agata A Exner; Massimo Mischi; Simona Turco
Journal:  Sci Rep       Date:  2022-08-10       Impact factor: 4.996

7.  Editorial: Biomedical advances in ultrasound-mediated drug/molecule delivery.

Authors:  Agata A Exner; Jean-Michel Escoffre
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.